Skip to main content
. 2024 Mar 2;12(5):581. doi: 10.3390/healthcare12050581

Table 2.

Histopathological features of patients with DTC, according to their BMI group.

Normal Weight Overweight Obesity p Value *
BMI 18.5–24.9 BMI 25–29.9 BMI ≥ 30
N = 66, 31.3% N = 81, 38.4% N = 64, 30.3%
T pT (n, %) pT 1–2 55, 83.33% 63, 77.78% 50, 78.13% * 0.763
a 0.484
pT 3–4 11, 16.67% 17, 20.99% 13, 20.31% b 0.563
c 0.929
Histological sub-type (n, %) PTC 60, 90.91% 75, 92.59% 60, 93.75% * 1
a 1
FTC 5, 7.58% 6, 7.41% 4, 6.25% b 1
c 1
PTC variant (n, %) Classic 32, 48.48% 25, 30.86% 20, 31.25% * 0.62
a 0.6
Follicular 24, 36.36% 41, 50.62% 30, 46.88% b 0.332
Aggressive ¥ 4, 6.06% 9, 11.11% 10, 15.63% c 0.69
Multifocality (n, %) 26, 39.39% 38, 46.91% 24, 37.5% * 0.486
a 0.403
b 0.771
c 0.255
Any extrathyroidal extension (n, %) 14, 21.21% 23, 28.4% 20, 31.25% * 0.399
a 0.345
b 0.232
c 0.717
LN LN MTS (n, %) No 52, 78.79% 59, 72.84% 41, 64.06% * 0.349
a 0.372
N1a 6, 9.09% 14, 17.28% 13, 20.31% b 0.129
N1b 7, 10.61% 8, 9.88% 9, 14.06% c 0.576
Bilateral lateral neck LN MRS (n, %) 0, 0% 2, 2.47% 3, 4.69% * 0.233
a 0.502
b 0.116
c 0.655
LN diameter ≥ 3 cm # (n, %) 2, 3.03% 0, 0% 4, 6.25% * 0.037
a 0.2
b 0.437
c 0.036
Extra-nodal extension # (n, %) 4, 6.06% 7, 8.64% 8, 12.5% * 0.436
a 0.754
b 0.204
c 0.46
Distal MTS (n, %) 4, 6.06% 2, 2.47% 0, 0% * 0.134
a 0.407
b 0.119
c 0.504

* Comparison of all 3 sub-groups, a—overweight versus normal weight, b—obese versus normal weight, c—obese versus overweight; ¥ tall cell, columnar, and insular variants of PTC together with moderately and poorly differentiated variants; # one or more. Abbreviations: DTC—differentiated thyroid carcinoma, BMI—body mass index (body weight [Kg] divided by the squire of height [meters]), T—primary tumor characteristics, PTC—papillary thyroid carcinoma, FTC—follicular thyroid carcinoma, LN—lymph node/s, MTS—metastasis.